🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/05/2014 | 53,82 | 54,18 | 53,47 | 53,90 | -0,16% | 1,31% | 7.522.544 |
| 21/05/2014 | 53,63 | 54,03 | 53,56 | 53,99 | +1,04% | 0,87% | 6.970.143 |
| 20/05/2014 | 53,65 | 53,68 | 53,18 | 53,44 | -0,62% | 0,94% | 8.232.983 |
| 19/05/2014 | 53,19 | 53,79 | 53,07 | 53,77 | +0,86% | 1,35% | 7.880.226 |
| 16/05/2014 | 53,11 | 53,68 | 53,11 | 53,31 | -0,04% | 1,08% | 9.496.976 |
| 15/05/2014 | 53,25 | 54,00 | 52,97 | 53,33 | -0,85% | 1,94% | 9.346.588 |
| 14/05/2014 | 53,08 | 53,97 | 53,08 | 53,79 | +1,11% | 1,67% | 8.171.780 |
| 13/05/2014 | 52,78 | 53,49 | 52,67 | 53,20 | +0,83% | 1,55% | 9.389.032 |
| 12/05/2014 | 53,07 | 53,07 | 52,34 | 52,76 | +0,14% | 1,38% | 8.473.080 |
| 09/05/2014 | 52,58 | 53,16 | 51,91 | 52,68 | +0,69% | 2,38% | 12.979.480 |
| 08/05/2014 | 53,01 | 53,21 | 52,21 | 52,32 | -1,81% | 1,87% | 15.061.227 |
| 07/05/2014 | 53,62 | 54,25 | 52,98 | 53,28 | -2,22% | 2,37% | 24.009.575 |
| 06/05/2014 | 56,06 | 56,08 | 54,43 | 54,49 | -2,59% | 2,94% | 14.502.538 |
| 05/05/2014 | 55,45 | 55,98 | 55,11 | 55,94 | +0,70% | 1,58% | 8.525.480 |
| 02/05/2014 | 56,75 | 56,80 | 55,29 | 55,55 | -2,35% | 2,67% | 12.659.106 |
| 01/05/2014 | 55,87 | 57,10 | 55,87 | 56,89 | +1,81% | 2,20% | 12.287.276 |
| 30/04/2014 | 55,83 | 56,30 | 55,36 | 55,88 | -0,27% | 1,67% | 14.211.299 |
| 29/04/2014 | 54,87 | 56,16 | 54,65 | 56,03 | +3,60% | 2,77% | 14.317.252 |
| 28/04/2014 | 54,97 | 55,20 | 53,89 | 54,08 | -0,98% | 2,38% | 17.807.826 |
| 25/04/2014 | 54,90 | 55,04 | 54,41 | 54,62 | -0,50% | 1,15% | 6.526.630 |
| 24/04/2014 | 54,69 | 55,17 | 54,25 | 54,90 | +0,05% | 1,69% | 7.037.110 |
| 23/04/2014 | 55,11 | 55,12 | 54,47 | 54,87 | -0,47% | 1,19% | 8.107.433 |
| 22/04/2014 | 54,48 | 55,65 | 54,41 | 55,12 | +0,91% | 2,28% | 14.642.866 |
| 21/04/2014 | 53,97 | 54,68 | 53,82 | 54,63 | +1,38% | 1,59% | 6.530.088 |
| 17/04/2014 | 53,86 | 54,39 | 53,69 | 53,88 | +0,37% | 1,29% | 11.804.358 |
| 16/04/2014 | 53,86 | 54,34 | 53,37 | 53,68 | +0,37% | 1,81% | 10.098.004 |
| 15/04/2014 | 53,23 | 53,73 | 52,59 | 53,48 | +0,86% | 2,15% | 11.677.759 |
| 14/04/2014 | 53,65 | 54,13 | 52,43 | 53,02 | -0,63% | 3,17% | 11.304.776 |
| 11/04/2014 | 53,01 | 54,01 | 52,77 | 53,36 | +0,13% | 2,34% | 14.286.022 |
| 10/04/2014 | 55,24 | 55,48 | 53,23 | 53,29 | -2,19% | 4,08% | 18.883.388 |